Shailly Tomar

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Crystal Structure

Respiratory Syndrome Coronavirus

Molecular Dynamics

Estrogen Receptor

Top Venues

Journal of biomolecular structure & dynamics

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, Prasan Kumar Panda, Pravindra Kumar, Gaurav Kumar Sharma, Shailly Tomar
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease. IUBMB life (2023)
Rajat Mudgal, Chandrima Bharadwaj, Aakriti Dubey, Shweta Choudhary, Perumal Nagarajan, Megha Aggarwal, Yashika Ratra, Soumen Basak, Shailly Tomar
Selective Estrogen Receptor Modulators Limit Alphavirus Infection by Targeting the Viral Capping Enzyme nsP1. Antimicrobial agents and chemotherapy 66 (3) (2022)
Akshay Pareek, Ravi Kumar, Rajat Mudgal, Neetu Neetu, Monica Sharma, Pravindra Kumar, Shailly Tomar
Alphavirus antivirals targeting RNA-dependent RNA polymerase domain of nsP4 divulged using surface plasmon resonance. The FEBS journal 289 (16) (2022)
Monica Sharma, Jai Krishna Mahto, Preeti Dhaka, Neetu Neetu, Shailly Tomar, Pravindra Kumar
MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2. Journal of biomolecular structure & dynamics (2021)
Aakriti Dubey, Shweta Choudhary, Pravindra Kumar, Shailly Tomar
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications. Current microbiology 79 (1) (2021)
Poonam Dhankhar, Vikram Dalal, Vishakha Singh, Shailly Tomar, Pravindra Kumar
Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2. Journal of biomolecular structure & dynamics (2020)
Rajat Mudgal, Supreeti Mahajan, Shailly Tomar
Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase. FEBS letters 594 (4) (2019)